News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
1743
Sources here
22
Companies here
25
Search results Stored financial headlines

Active search

1743 matching headlines

Ticker or company: TEXMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Texas Pacific Land (NYSE:TPL) Strong Profits May Be Masking Some Underlying Issues

Texas Pacific Land's recent solid earnings report may be masking underlying issues, particularly concerning its free cash flow. The company's accrual ratio of 0.43 indicates it didn't generate enough free cash flow to match its US$541.4m profit, with actual free cash flow at only …

TPL main company
Sharemaestro market context Price below Trend Line 52 weeks +18.7% TPL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Annex Advisory Services LLC Acquires 78,424 Shares of Texas Pacific Land Corporation $TPL

Annex Advisory Services LLC significantly increased its stake in Texas Pacific Land Corporation by acquiring an additional 78,424 shares, bringing its total holdings to 153,464 shares valued at $67.2 million. Texas Pacific Land recently reported earnings of $2.23 per share, surpassing estimates, and declared …

TPL main company
Sharemaestro market context Price below Trend Line 52 weeks +18.7% TPL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Optex Systems Hldgs Q3 Results: EPS drops 18% YoY, sales miss

Optex Systems Holdings (NASDAQ: OPXS) reported a disappointing third quarter with EPS of $0.18, missing analyst estimates by 14.29% and representing an 18.18% year-over-year decline. The company's sales of $9.729 million also fell short of forecasts by 20.90% and were down 12.43% from the …

OPXS main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% OPXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Optex Systems (OPXS) Q3 shows lower sales but stronger margins and cash

Optex Systems Holdings Inc. (OPXS) reported lower revenue but improved margins and a solid cash position for the quarter and nine months ending June 28, 2026. Quarterly revenue fell to $9.7 million from $11.1 million, and nine-month revenue decreased to $28.5 million from $30.0 …

OPXS main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% OPXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call

5 Insightful Analyst Questions From Vertex Pharmaceuticals's Q2 Earnings Call Vertex Pharmaceuticals' second quarter reflected strong commercial momentum, with management highlighting the performance of its cystic fibrosis (CF) portfolio and accelerating uptake of newer products like CASGEVY and JOURNAVX. CEO Reshma Kewalramani attributed revenue …

VRTX main company VRTX34 main company VRTX main company VX1 main company VRTX main company
Sharemaestro market context Trend signal active 52 weeks +16.9% VRTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: Optex Systems misses Q3 2026 revenue forecast

Optex Systems Holdings reported Q3 2026 earnings of $0.18 per share on revenue of $9.7 million, missing analyst expectations of $0.20 per share and $12.6 million. Despite the revenue miss, the company highlighted increased cash to $6.0 million, recent contract wins including an XM30 …

OPXS main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% OPXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OPXS: Strong revenue growth, improved cash, and new contract wins drive positive outlook

Optex Systems Holdings, Inc. (OPXS) reported strong revenue and earnings growth year-over-year due to increased demand and production. The company improved its cash position and saw its backlog rebound to $45 million after securing new contracts. OPXS remains focused on growth and potential opportunistic …

OPXS main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% OPXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Roadhouse (TXRH) trust plans 3,000-share sale under Form 144 notice

The Moore Family Trust, with Gregory Moore as trustee, has filed a Form 144 notice to sell 3,000 shares of Texas Roadhouse Inc. (TXRH) common stock. The proposed sale date is August 11, 2026, through UBS Financial Services Inc. These shares originated from a …

TXRH main company
Sharemaestro market context Trend signal active 52 weeks +18.8% · Next-week setup positive 58.9% TXRH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Textron Inc. stock outperforms competitors despite losses on the day

Textron Inc. (TXT) saw its stock fall by 1.11% to $88.21, marking its second consecutive day of losses. Despite this decline, the stock still outperformed the broader market, as the S&P 500 Index (SPX) dropped 0.32% and the Dow Jones Industrial Average (DJIA) fell …

TXT main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% · Next-week setup positive 55.4% TXT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Texas Instruments (TXN) Overvalued, Or Is Fair Value Higher?

Texas Instruments (TXN) has seen a significant 79.2% return over the past three years, but current analyses suggest it may be overvalued. Both Discounted Cash Flow (DCF) and P/E ratio assessments indicate the stock is trading at a premium, with the DCF model estimating …

TXN main company TXN main company TXN main company
Sharemaestro market context Trend signal active 52 weeks +60.0% TXN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Optex Systems Holdings reports Q3 revenue $9.7M, gross margin 34.2%, net income $1.3M

Optex Systems Holdings (OPXS) reported Q3 fiscal 2026 revenue of $9.7 million and net income of $1.3 million. Despite a quarter-over-quarter revenue decrease due to delivery timing changes, the company improved its gross margin to 34.2% and reiterated its full-year revenue and Adjusted EBITDA …

OPXS main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% OPXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Instruments (TXN) Following GE Appliances Deal Is The Stock Still Undervalued

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. GE Appliances' decision to source one third of the chips for its new Kentucky laundry plant from Texas Instruments (TXN) puts fresh attention on …

TXN main company TXN main company TEXA34 main company TXN main company TII main company TXN main company
Sharemaestro market context Trend signal active 52 weeks +60.0% TXN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PowerPro Equipment Named Jacobsen Dealer for the Mid-Atlantic Region

Textron Specialized Vehicles Inc. has appointed PowerPro Equipment as its newest authorized dealer for Jacobsen professional turf equipment in the Mid-Atlantic region. PowerPro Equipment will offer sales, service, and support for Jacobsen and Ransomes turf equipment across several states and will enhance Jacobsen's presence …

TXT main company
Sharemaestro market context Price below Trend Line 52 weeks +9.3% · Next-week setup positive 55.4% TXT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Texas Instruments (TXN) Stock Looks Stretched Against Its Fair Value

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Texas Instruments stock has delivered a strong 79.2% return over the past three years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and …

TXN main company TXN main company TEXA34 main company TXN main company TII main company TXN main company
Sharemaestro market context Trend signal active 52 weeks +60.0% TXN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Crinetics Pharmaceuticals stock hits all-time high at 84.35 USD By Investing.com

Crinetics Pharmaceuticals (CRNX) stock reached an all-time high of $84.35, currently trading 1% below its 52-week high, with a market capitalization of $8.94 billion. The stock has seen a 196.14% increase over the past year, or 207% according to InvestingPro data, though its RSI …

VRTX main company
Sharemaestro market context Trend signal active 52 weeks +28.0% VRTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

VTEX CEO Geraldo do Carmo Thomaz Junior Sells 4,808 Class A Shares Under Rule 10b5-1 Plan

VTEX CEO Geraldo do Carmo Thomaz Junior sold 4,808 Class A Common Shares on August 10, 2026, under a Rule 10b5-1 trading plan adopted in October 2025. The shares were sold at a weighted average price of $4.05, with individual prices ranging from $4.00 …

VTEX main company
Sharemaestro market context Trend signal active 52 weeks -10.7% VTEX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Here is Why Growth Investors Should Buy Texas Roadhouse (TXRH) Now

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all. In addition to volatility, these stocks carry above-average risk by …

TXRH main company
Sharemaestro market context Trend signal active 52 weeks +18.8% · Next-week setup positive 58.9% TXRH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

$100 Invested In Texas Instruments 15 Years Ago Would Be Worth This Much Today

Texas Instruments (NASDAQ: TXN) has outperformed the market over the past 15 years, achieving an average annual return of 16.97%. An initial investment of $100 in TXN stock 15 years ago would now be worth $1,049.65. This demonstrates the significant impact of compounded returns …

TXN main company
Sharemaestro market context Trend signal active 52 weeks +38.5% TXN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context